David Ospina, MD | |
130 Fisher Rd, Mob-b, Ste 3, Berlin, VT 05602-9516 | |
(802) 225-5400 | |
(802) 225-5401 |
Full Name | David Ospina |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 37 Years |
Location | 130 Fisher Rd, Berlin, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689660912 | NPI | - | NPPES |
OVN1756 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 9677 (Vermont) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | 0420009677 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Central Vermont Home Health & Hospice | Barre, VT | Hospice |
Central Vermont Medical Center | Barre, VT | Hospital |
Copley Hospital | Morrisville, VT | Hospital |
Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Vermont Medical Center Inc | 9335138817 | 204 |
Copley Hospital Inc | 9234125766 | 49 |
News Archive
NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.
A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
The number of women diagnosed with breast cancer per year in the seven major markets is forecast to increase by 13% over the next decade, finds independent healthcare analyst, Datamonitor.* However, in Japan, breast cancer incidence rates will rise by approximately 24% to 2019 to reach 56,400 cases, compared to 45,600 cases in 2010.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 1 days ago
Entity Name | Copley Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922029784 PECOS PAC ID: 9234125766 Enrollment ID: O20040811001413 |
News Archive
NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.
A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
The number of women diagnosed with breast cancer per year in the seven major markets is forecast to increase by 13% over the next decade, finds independent healthcare analyst, Datamonitor.* However, in Japan, breast cancer incidence rates will rise by approximately 24% to 2019 to reach 56,400 cases, compared to 45,600 cases in 2010.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 1 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.
A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
The number of women diagnosed with breast cancer per year in the seven major markets is forecast to increase by 13% over the next decade, finds independent healthcare analyst, Datamonitor.* However, in Japan, breast cancer incidence rates will rise by approximately 24% to 2019 to reach 56,400 cases, compared to 45,600 cases in 2010.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
David Ospina, MD Po Box 547, Central Vermont Medical Center - Finance Dept, Barre, VT 05641-0547 Ph: (802) 225-5400 | David Ospina, MD 130 Fisher Rd, Mob-b, Ste 3, Berlin, VT 05602-9516 Ph: (802) 225-5400 |
News Archive
NextGate, a leader in the IT indexing field, today announced that Geisinger Health System, widely recognized for its advanced electronic health record (EHR) and execution of innovative care models, is implementing NextGate's patient indexing software. The software will enhance the coordination of patient data across the health system and enable care providers to access patients' most up-to-date clinical information regardless of location.
A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society's 2008 International Conference in Toronto on Tuesday, May 20.
The number of women diagnosed with breast cancer per year in the seven major markets is forecast to increase by 13% over the next decade, finds independent healthcare analyst, Datamonitor.* However, in Japan, breast cancer incidence rates will rise by approximately 24% to 2019 to reach 56,400 cases, compared to 45,600 cases in 2010.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 1 days ago
Laura Allen Felsted, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3, Mountainview Medical, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Devika Singh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-b Suite 3, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Brett Erdreich, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100 | |
Dr. Joachim Georg Mueller, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Cardiology Mob-a Suite 2-1, Berlin, VT 05602 Phone: 802-225-5660 Fax: 802-229-9533 | |
Sarah E Swift, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Hannah Swayze-quinn, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Peter Alan Redford, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 |